4th Quarter - Report

OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.

Firm
Client
Income
—
Expenses
$360,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

42 CFR Part 2, Kidney Disease, Mental Health

LobbyistCovered position, as disclosed
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare Part D Redesign, Drug Pricing (H.R.3, SFC bill PDPRA)

LobbyistCovered position, as disclosed
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.